PROGNOSTIC MARKER ANALYSIS IN PEDIATRIC POSTERIOR FOSSA EPENDYMOMAS

Por McLendon, Roger E., Lipp, Eric, Gururangan, Sri, Fuchs, Herb, Zagzag, David, Herndon, James, Healy, Patrick
Publicado em 2014

SM-02 LEVETIRACETAM USAGE IN POST-OPERATIVE SEIZURE MANAGEMENT IN MALIGNANT GLIOMA

Por Kang, Jennifer, Desjardins, Annick, Healy, Patrick, Herndon, James, Lipp, Eric, Peters, Katherine, Vlahovic, Gordana, Sampson, John, Friedman, Henry, Friedman, Allan, Adamson, Cory
Publicado no Neuro Oncol (2014)

AT-20 SINGLE INSTITUTION RETROSPECTIVE REVIEW OF PERFORMANCE STATUS AND CORTICOSTEROID USE IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PATIENTS (PTS) TREATED ON BEVACIZUMAB (BEV)

Por Desjardins, Annick, Herndon, James, McSherry, Frances, Ravelo, Arliene, Lipp, Eric, Healy, Patrick, Peters, Katherine, Vlahovic, Gordana, Sampson, John, Friedman, Allan, Friedman, Henry
Publicado em 2014

QOL-19 PROSPECTIVE EVALUATION OF CARDIOPULMONARY FITNESS IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS RECEIVING AN ANTI-ANGIOGENIC REGIMEN

Por Ghiaseddin, Ashley, West, Miranda, Hornsby, Whitney, Freeman, Maria, Lipp, Eric, McSherry, Frances, Herndon, James, Desjardins, Annick, Friedman, Henry, Jones, Lee, Peters, Katherine
Publicado no Neuro Oncol (2015)

Association between body mass index and mortality in patients with glioblastoma mutliforme

Por Jones, Lee W., Ali-Osman, Francis, Lipp, Eric, Marcello, Jennifer E., McCarthy, Bridget, McCoy, Lucie, Rice, Terri, Wrensch, Margaret, Il'yasova, Dora
Publicado em 2010

AT-19 SINGLE INSTITUTION RETROSPECTIVE COMPARISON OF GLIOBLASTOMA (GBM) PATIENTS (PTS) INITIATED ON BEVACIZUMAB (BEV) BEFORE VERSUS AFTER RECURRENCE IN CLINICAL PRACTICE

Por Desjardins, Annick, Herndon, James, McSherry, Frances, Ravelo, Arliene, Lipp, Eric, Healy, Patrick, Boulton, Susan, Peters, Katherine, Vlahovic, Gordana, Sampson, John, Friedman, Allan, Friedman, Henry
Publicado em 2014

AT-46 VORINOSTAT AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA: INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL

Por Peters, Katherine, Reardon, David, Randazzo, Dina, Dutton, Shelley, Edwards, Ashley, Lipp, Eric, Herndon, James, McSherry, Frances, Desjardins, Annick, Ranjan, Tulika, Vlahovic, Gordana, Friedman, Henry
Publicado em 2014

Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma

Por Peters, Katherine B., Lou, Emil, Desjardins, Annick, Reardon, David A., Lipp, Eric S., Miller, Elizabeth, Herndon, James E., McSherry, Frances, Friedman, Henry S., Vredenburgh, James J.
Publicado no Oncologist (2015)

AT-48 A PHASE 1 TRIAL OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) IN COMBINATION WITH BEVACIZUMAB FOR ADULT PATIENTS WITH RECURRENT MALIGNANT GLIOMA POST-BEVACIZUMAB FAILURE

Por Ranjan, Tulika, Peters, katherine B., Vlahovic, Gordana, Watts, Jason, Dutton, Shelley, Boulton, Susan, Lipp, Eric, Herndon, James, Healy, Patrick, Miller, Elizabeth, Friedman, Henry, Karmali, Rashida, Desjardins, Annick
Publicado em 2014

Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma

Por Lou, Emil, Peters, Katherine B, Sumrall, Ashley L, Desjardins, Annick, Reardon, David A, Lipp, Eric S, Herndon, James E, Coan, April, Bailey, Leighann, Turner, Scott, Friedman, Henry S, Vredenburgh, James J
Publicado em 2013

AT-21 FINAL RESULTS OF A PHASE 1 TRIAL OF AN ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) AGAINST RECURRENT GLIOBLASTOMA (GBM)

Por Desjardins, Annick, Sampson, John, Peters, Katherine, Vlahovic, Gordana, Threatt, Stevie, Herndon, James, Boulton, Susan, Lally-Goss, Denise, McSherry, Frances, Lipp, Eric, Friedman, Allan, Friedman, Henry, Bigner, Darell, Gromeier, Matthias
Publicado em 2014

MRP3: a molecular target for human glioblastoma multiforme immunotherapy.

Por Kuan, Chien-Tsun, Wakiya, Kenji, Herndon, James E, Lipp, Eric S, Pegram, Charles N, Riggins, Gregory J, Rasheed, Ahmed, Szafranski, Scott E, McLendon, Roger E, Wikstrand, Carol J, Bigner, Darell D
Publicado em 2010

Radioimmunotargeting of Malignant Glioma by Monoclonal Antibody D2C7 Reactive Against Both Wild-Type and Variant III Mutant Epidermal Growth Factor Receptors

Por Zalutsky, Michael R., Boskovitz, Abraham, Kuan, Chien-Tsun, Pegram, Charles N, Ayriss, Joanne, Wikstrand, Carol J, Buckley, Anne F., Lipp, Eric S., Herndon, James E., McLendon, Roger E., Bigner, Darell D.
Publicado em 2011

ATCT-01 PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RILOTUMUMAB AND BEVACIZUMAB (BEV) IN SUBJECTS WITH RECURRENT MALIGNANT GLIOMA (MG)

Por Affronti, Mary L., Friedman, Henry S., Desjardins, Annick, Vlahovic, Gordana, Randazzo, Dina M., Herndon, James E., McSherry, Frances, Lipp, Eric S., Mannerico, Alex, Massey, Woody, Miller, Elizabeth, Iden, Deborah, Peters, Katherine B.
Publicado no Neuro Oncol (2015)

Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients

Por Reardon, David A., Herndon, James E., Peters, Katherine, Desjardins, Annick, Coan, April, Lou, Emil, Sumrall, Ashley, Turner, Scott, Sathornsumetee, Sith, Rich, Jeremy N., Boulton, Susan, Lipp, Eric S., Friedman, Henry S., Vredenburgh, James J.
Publicado em 2011

Phase II study of Gleevec® plus hydroxyurea in adults with progressive or recurrent low-grade glioma()

Por Reardon, David A., Desjardins, Annick, Vredenburgh, James J., Herndon, James E., Coan, April, Gururangan, Sridharan, Peters, Katherine B., McLendon, Roger, Sathornsumetee, Sith, Rich, Jeremy N., Lipp, Eric S., Janney, Dorothea, Friedman, Henry S.
Publicado em 2012

The genetic landscape of anaplastic astrocytoma

Por Killela, Patrick J., Pirozzi, Christopher J., Reitman, Zachary J., Jones, Sian, Rasheed, B. Ahmed, Lipp, Eric, Friedman, Henry, Friedman, Allan H., He, Yiping, McLendon, Roger E., Bigner, Darell D., Yan, Hai
Publicado em 2013

QL-21 SPIRITUAL WELL-BEING AND ITS ASSOCIATION WITH HEALTH-RELATED QUALITY OF LIFE IN PRIMARY BRAIN TUMOR PATIENTS

Por Randazzo, Dina, Affronti, Mary, Lipp, Eric, McSherry, Frances, Herndon, James, Flahiff, Charlene, Miller, Elizabeth, Woodring, Sarah, Freeman, Maria, Healy, Patrick, Minchew, Janet, Boulton, Susan, Desjardins, Annick, Ranjan, Tulika, Vlahovic, Gordana, Friedman, Henry, Peters, Katherine
Publicado em 2014

Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: Implications for drug development

Por Brown, Kristine E., Chagoya, Gustavo, Kwatra, Shawn G., Yen, Timothy, Keir, Stephen T., Cooter, Mary, Hoadley, Katherine A., Rasheed, Ahmed, Lipp, Eric S., Mclendon, Roger, Ali-Osman, Francis, Bigner, Darell D., Sampson, John H., Kwatra, Madan M.
Publicado no J Neurochem (2015)

QL-20 PROGNOSTIC IMPORTANCE OF HEALTH-RELATED QUALITY OF LIFE AND FATIGUE IN NEWLY DIAGNOSED GLIOBLASTOMA

Por Peters, Katherine, Randazzo, Dina, Affronti, Mary, Lipp, Eric, McSherry, Frances, Herndon, James, Flahiff, Charlene, Miller, Elizabeth, Woodring, Sarah, Freeman, Maria, Healy, Patrick, Minchew, Janet, Boulton, Susan, Desjardins, Annick, Ranjan, Tulika, Vlahovic, Gordana, Jones, Lee, Friedman, Henry
Publicado em 2014